Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease

Published:2018-03 Issue:3 Volume:141 Page:1122-1124.e11
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Knobloch Jürgen,Jungck David,Charron Catherine,Stoelben Erich,Ito Kazuhiro,Koch Andrea

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease;Barnes;J Allergy Clin Immunol,2013

2. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease;Knobloch;J Pharmacol Exp Ther,2010

3. Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism;Knobloch;Am J Respir Cell Mol Biol,2013

4. Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449;Norman;Expert Opin Ther Pat,2014

5. Discovery of narrow-spectrum kinase inhibitors: new therapeutic agents for the treatment of COPD and steroid-resistant asthma;Onions;J Med Chem,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p38 mitogen-activated protein kinase inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

2. Progress in the development of kinase inhibitors for treating asthma and COPD;Advances in Pharmacology;2023

3. Therapeutic Effects and Molecular Mechanisms of Bioactive Compounds Against Respiratory Diseases: Traditional Chinese Medicine Theory and High-Frequency Use;Frontiers in Pharmacology;2021-08-27

4. Pseudomonas aeruginosa induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway;PLOS ONE;2021-02-01

5. Novel Immunomodulatory Therapies for Respiratory Pathologies;Reference Module in Biomedical Sciences;2021